On 27 September 2019, the XII Foresight Training Course will take place in Toulouse (France) and will foresee the workshop “Innovative medicine and research: ethical, legal and regulatory issues”. The event is organised by Fondazione per la Ricerca Farmacologica...
SAVE THE DATE. 28th ERTC Workshop “A New PARADIGM of Meaningful Patient Engagement in the Life Cycle of Medicines” 15th October 2019, Barcelona, Spain
EURORDIS – Rare Disease Europe will organise the 28th EURORDIS Round Table of Companies Workshop on 15 October 2019 at the Hospital Sant Pau Recinte Modernista in Barcelona, Spain. The workshop entitled “A new PARADIGM of Meaningful Patient Engagement in the Life...
SAVE THE DATE. “Shaping the Future of Paediatrics”, the Conference organized by Bambino Gesù Children’s Hospital in Rome on 2th-4th October 2019
On 2th-4th October 2019 Bambino Gesù Children’s Hospital in partnership with the International Society of Pediatric Innovation (iSPI) will organise the Conference “Shaping the Future of Paediatrics” at Centro Congressi Piazza di Spagna in Rome. The Conference will...
SAVE THE DATE. RESTORE Advanced Therapies Science Meeting on 25th and 26th November 2019 in Berlin: the TEDDY Network submitted 5 Abstracts
On 25th and 26th November 2019, the RESTORE First Advanced Therapies Science Meeting will take place in Berlin. The conference will highlight the science behind Advanced Therapies with a jam-packed agenda featuring leaders in science and technology development. TEDDY...
TEDDY Working group on Off-Label is working on a guide for off-label use in paediatrics
The European Medicines Agency defines “off-label” the use of a medicine for an unapproved indication or in an unapproved age group, dosage, or route of administration. The majority of marketed medicines world‐wide, including those commonly used or which could...
EMA – New treatment for children with type 2 diabetes
Type 2 diabetes is a chronic disease in which the pancreas does not make enough insulin to control the level of glucose (sugar) in the blood or when the body is unable to use insulin effectively. It can lead to serious complications if a person does not receive...
Have a look at the EJP RD events and training activities
The European Joint Programme on Rare Diseases (EJPRD) is a Co-fund action aimed to create a comprehensive, sustainable system allowing virtuous circle between research, care and medical innovation. TEDDY Network participates as Partner in this project and all of its...
European Commission launches online public survey on HORIZON EUROPE
The Commission is preparing for the crucial phases of the implementation of Horizon Europe (HE), the next EU research and innovation programme (2021-2027) with a proposed budget of 100 billion. In view of an intensive co-design approach, the Commission has launched an...
TEDDY involvement in the ENCePP activities focused on the EU PAS Register review
The European Union electronic Register of Post-Authorisation Studies (EU PAS Register) is a collection of non-interventional post-authorisation studies (PAS) and was launched in 2010 by ENCePP (European Network of Centres for Pharmacoepidemiology and...
The Italian Medicines Agency AIFA withdraws the paediatric indication for domperidone-containing products
The Italian Medicines Agency AIFA has just released a safety communication about the use of medicines containing domperidone. Domperidone-containing medicines have been authorised nationally in individual Member States of the EU for the treatment of nausea and...